SCHEMBL2887154

SCHEMBL2887154

COc1ccc(Sc2ccccc2OC)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
POLB P06746 1/20 0.55
MMP2 P08253 5/20 0.52
MMP9 P14780 5/20 0.52
MMP12 P39900 5/20 0.52
SLC6A9 P48067 1/20 0.52
HTR1A P08908 1/20 0.50
HTR3A P46098 1/20 0.50
PTGIR P43119 3/20 0.49
MMP14 P50281 1/20 0.47
ALDH1A1 P00352 3/20 0.47
DHFR P00374 1/20 0.47
MAPT P10636 1/20 0.47
HAO1 Q9UJM8 1/20 0.46
HTT P42858 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPK1 P28482 1/20 0.45
CA4 P22748 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30548759 0.88 MEN1 (0.62) MEN1KMT2APOLBMMP2MMP9
SCHEMBL20955831 0.87 LTA4H (0.52) ARMEN1KMT2APOLBMMP2
SCHEMBL29587704 0.87 LTA4H (0.52) ARMEN1KMT2APOLBMMP2
SCHEMBL30580501 0.86 LTA4H (0.55) ARMEN1KMT2APOLBMMP2
SCHEMBL3289071 0.86 AR (0.56) ARMEN1KMT2APOLBSLC6A9
SCHEMBL31345522 0.85 AR (0.55) ARMEN1KMT2APOLBSLC6A9
SCHEMBL23720058 0.83 AR (0.54) ARMEN1KMT2APOLBPTGIR
SCHEMBL15418635 0.83 AR (0.54) ARMEN1KMT2APOLBMMP2
SCHEMBL29363270 0.83 AR (0.54) ARMEN1KMT2APOLBMMP2
SCHEMBL3984466 0.82 SLC6A9 (0.54) MEN1KMT2APOLBMMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7683218-B2 Method for producing thioether compound BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-03-23 US disclosed
US-20080108823-A1 Method For Producing Thioether Compound MSD K.K. (JP) 2008-05-08 US disclosed
EP-1806337-A1 METHOD FOR PRODUCING THIOETHER COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-07-11 EP disclosed
US-4124370-A Diphenyl ethers for tobacco sucker control ROHM AND HAAS COMPANY (US) 1978-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108823-A1 Method For Producing Thioether Compound TST, MPST, PPIP5K2 AR 1841/4885MEN1 2589/4885KMT2A 1791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.